Clik here to view.
Reminder: Ligand to Host Analyst Day on February 28th in New York City
Monday, February 13th 2017 at 9:30pm UTC SAN DIEGO–(BUSINESS WIRE)– Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) will host an Analyst Day on Tuesday, February 28, 2017 from 10:00 a.m. to 11:30...
View ArticleClik here to view.
Acorda Provides Financial and Pipeline Update for Fourth Quarter and Year End...
Tuesday, February 14th 2017 at 11:00am UTC AMPYRA® (dalfampridine) 4Q 2016 Net Revenue of $132 Million; Full-Year Net Revenue of $493 Million AMPYRA 2017 Net Sales Guidance of $535-$545 Million...
View ArticleClik here to view.
FlowAid Receives FDA US Market Clearance for the FA100 SCCD
Wednesday, February 15th 2017 at 12:20pm UTC The FA100 SCCD is a unique hospital and home use device for the integrative treatment of diseases and discomforts that can be relieved by increased blood...
View ArticleClik here to view.
Puma Biotechnology to Present at RBC Capital Markets Healthcare Conference
Tuesday, February 14th 2017 at 9:15pm UTC LOS ANGELES–(BUSINESS WIRE)– Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive...
View ArticleClik here to view.
Amgen’s Repatha CVOT Results Are Potential Game-Changer for Lipid-Lowering...
Wednesday, February 15th 2017 at 3:00pm UTC Seen as market catalyst for Amgen and other developers of competing lipid-lowering therapies:BioPharm Insight Cardiology Report NEW YORK–(BUSINESS WIRE)– In...
View ArticleClik here to view.
Pfizer Announces Top-Line Results from the Oral Strategy Trial of XELJANZ®...
Thursday, February 16th 2017 at 1:00pm UTC NEW YORK–(BUSINESS WIRE)– Pfizer Inc. (NYSE:PFE) announced today top-line results from ORAL Strategy, a Phase 3B/4 study of XELJANZ® (tofacitinib citrate)...
View ArticleClik here to view.
Biogen to Present at the 2017 RBC Capital Markets Global Healthcare Conference
Wednesday, February 15th 2017 at 10:29pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Biogen Inc. (NASDAQ: BIIB) announced today that it will present at the 2017 RBC Capital Markets Global Healthcare...
View ArticleClik here to view.
ICON Reports Fourth Quarter and Full Year 2016 Results
Thursday, February 16th 2017 at 11:00am UTC Highlights Quarter 4 gross business wins of $605 million, a gross book to bill of 1.39. Net business wins of $434 million, a net book to bill of 1.0. Full...
View ArticleClik here to view.
New Data in Crohn’s Disease Patients Shows Similar Efficacy and Safety...
Friday, February 17th 2017 at 5:00pm UTC Pfizer in partnership with Celltrion Healthcare presents new data for INFLECTRA in Crohn’s disease NEW YORK–(BUSINESS WIRE)– Data announced jointly today by...
View ArticleClik here to view.
Catherine D. Strader, Ph.D., Joins Acorda Therapeutics Board of Directors
Tuesday, February 21st 2017 at 12:00pm UTC ARDSLEY, N.Y.–(BUSINESS WIRE)– Acorda Therapeutics, Inc. (Nasdaq:ACOR) today announced that Catherine D. Strader, Ph.D., has joined its board of directors,...
View ArticleClik here to view.
Pfizer Announces Acceptance of Regulatory Submission for Inotuzumab...
Tuesday, February 21st 2017 at 1:00pm UTC Application Requests Approval for the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia in Adults NEW YORK–(BUSINESS WIRE)– Pfizer Inc....
View ArticleClik here to view.
Goodix to Unveil World-Leading New Innovations at Mobile World Congress 2017
Tuesday, February 21st 2017 at 10:15pm UTC SHENZHEN–(BUSINESS WIRE)– Goodix, the world leader in human interface and biometric technologies, announced today that it will unveil another world’s first...
View ArticleClik here to view.
Eagle Pharmaceuticals Announces New Patents Issued for Bendeka
Tuesday, February 21st 2017 at 2:34pm UTC — Bendeka protected by 10 patents running from 2026 through 2033 – — Total of nine Orange Book listed patents – — Additional four patents allowed — WOODCLIFF...
View ArticleClik here to view.
Bristol-Myers Squibb Appoints Three New Independent Directors
Tuesday, February 21st 2017 at 11:59am UTC Announces $2 Billion Accelerated Share Repurchase Program NEW YORK–(BUSINESS WIRE)– Bristol-Myers Squibb Company (NYSE:BMY) announced today that it has...
View ArticleClik here to view.
venBio Sends Letter to Immunomedics Stockholders
Wednesday, February 22nd 2017 at 1:32pm UTC venBio Committed to Delivering Much-needed Change at Immunomedics Believes Immunomedics Lawsuit to Silence Stockholders is Baseless venBio’s Four Board...
View ArticleClik here to view.
Ophthotech Corporation to Report Fourth Quarter and Full Year 2016 Financial...
Wednesday, February 22nd 2017 at 12:30pm UTC NEW YORK–(BUSINESS WIRE)– Ophthotech Corporation (Nasdaq:OPHT) today announced that it will report its fourth quarter and full year 2016 financial and...
View ArticleClik here to view.
Philips Reinforces Leadership in Image-Guided Therapy Solutions with Global...
Wednesday, February 22nd 2017 at 4:15pm UTC Developed in collaboration with leading hospitals worldwide, Philips Azurion is an innovative image-guided therapy platform that allows clinicians to easily...
View ArticleClik here to view.
Crede Dismisses Claims in Lawsuit Against 22nd Century
Wednesday, February 22nd 2017 at 2:46pm UTC Dismissed Claims Were Frivolous and Completely Without Merit CLARENCE, N.Y.–(BUSINESS WIRE)– 22nd Century Group, Inc. (NYSE MKT: XXII), a plant...
View ArticleClik here to view.
Bristol-Myers Squibb Prices $1.5 Billion of Senior Notes
Wednesday, February 22nd 2017 at 11:00pm UTC NEW YORK–(BUSINESS WIRE)– Bristol-Myers Squibb Company (NYSE:BMY) today announced that it has agreed to sell $1.5 billion of senior unsecured notes: $750...
View ArticleClik here to view.
Ronald E. Blaylock Elected to Pfizer’s Board of Directors
Thursday, February 23rd 2017 at 9:15pm UTC NEW YORK–(BUSINESS WIRE)– Pfizer Inc. today announced the election of Ronald E. Blaylock to its Board of Directors, effective immediately. Mr. Blaylock was...
View Article